Industry News

You can read our Premium News Service in full if you have an Annual Subscription to the OTCToolbox website. You can read Basic News stories free of charge.

Perrigo set to launch Nasonex 24HR Allergy in US
Premium

18 March 2022

Perrigo has switched the allergy medicine Nasonex (mometasone furoate monohydrate) from prescription-to-OTC status in the US. Nasonex 24HR Allergy joins a small number of brands marketed by Perrigo in the US where it specialises in store-brand products.

Read the full story